Engineering advanced antibody molecules employs all the scientific and engineering tools modern science has to offer. In the 1990s, major breakthroughs in creating monoclonal antibodies led to unprecedented approvals by the U.S. Food and Drug Administration for commercial therapeutic uses of humanized antibodies. Today, more…
Month: January 2013
